Michele Dal Bo

4.4k total citations · 1 hit paper
86 papers, 1.9k citations indexed

About

Michele Dal Bo is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Michele Dal Bo has authored 86 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Genetics, 32 papers in Immunology and 29 papers in Molecular Biology. Recurrent topics in Michele Dal Bo's work include Chronic Lymphocytic Leukemia Research (45 papers), Lymphoma Diagnosis and Treatment (21 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). Michele Dal Bo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (45 papers), Lymphoma Diagnosis and Treatment (21 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). Michele Dal Bo collaborates with scholars based in Italy, Switzerland and United States. Michele Dal Bo's co-authors include Giuseppe Toffoli, Valter Gattei, Riccardo Bomben, Giovanni Del Poeta, Antonella Zucchetto, Paolo Macor, Massimo Degan, Francesca Maria Rossi, Gianluca Gaïdano and Pietro Bulian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Michele Dal Bo

80 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy

2023 108 citations Michele Dal Bo, Paolo Macor et al. profile →

Peers

Michele Dal Bo

GENET

IMMUN

PFM

ONCOL

Kumudha Balakrishnan United States

Nancy D. Bone United States

Charla Secreto United States

Zijun Y. Xu‐Monette United States

Pina M. Cardarelli United States

Güllü Görgün United States

Sari H. Enschede United States

John Sarantopoulos United States

Sonia Vallet United States

Evelyn McKeegan United States

Kumudha Balakrishnan United States

Michele Dal Bo

1.5k ×1.8

GENET

684 ×1.1

IMMUN

1.2k ×2.0

893 ×1.5

PFM

484 ×1.4

ONCOL

Citations per year, relative to Michele Dal Bo Michele Dal Bo (= 1×) peers Kumudha Balakrishnan

Countries citing papers authored by Michele Dal Bo

Since Specialization

Citations

This map shows the geographic impact of Michele Dal Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Dal Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Dal Bo more than expected).

Fields of papers citing papers by Michele Dal Bo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Dal Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Dal Bo. The network helps show where Michele Dal Bo may publish in the future.

Co-authorship network of co-authors of Michele Dal Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Dal Bo. A scholar is included among the top collaborators of Michele Dal Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Dal Bo. Michele Dal Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miolo, Gianmaria, et al.. (2025). Novel De Novo BRCA2 Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway. International Journal of Molecular Sciences. 26(5). 2295–2295.

Rasool, Maria, et al.. (2025). CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View. Cancer Medicine. 14(5). e70726–e70726. 6 indexed citations

Bo, Michele Dal, et al.. (2024). Targeted therapy for multiple myeloma: an overview on CD138-based strategies. Frontiers in Oncology. 14. 1370854–1370854. 5 indexed citations

Maso, Luca De, Marcello Manfredi, Giuseppe Toffoli, et al.. (2024). Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model. International Journal of Nanomedicine. Volume 19. 13267–13286. 9 indexed citations

Bo, Michele Dal, Maurizio Polano, Tamara Ius, et al.. (2023). Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection. Journal of Translational Medicine. 21(1). 450–450. 7 indexed citations

Maso, Luca De, Paolo Bertoncin, Thilo Kähne, et al.. (2023). Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles. Journal of Nanobiotechnology. 21(1). 376–376. 12 indexed citations

Maso, Luca De, et al.. (2022). Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs. Biomedicines. 10(9). 2252–2252. 6 indexed citations

Toffoli, Giuseppe, et al.. (2022). Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System. Pharmaceutics. 14(12). 2605–2605. 75 indexed citations

Bo, Michele Dal, et al.. (2021). Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model. Pharmaceutics. 13(8). 1106–1106. 10 indexed citations

10.

Pozzo, Federico, Tamara Bittolo, Elena Vendramini, et al.. (2017). NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. Leukemia. 31(11). 2407–2415. 46 indexed citations

11.

Bo, Michele Dal, Erika Tissino, Dania Benedetti, et al.. (2016). Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia. Current Cancer Drug Targets. 16(8). 659–668. 9 indexed citations

12.

Bo, Michele Dal, Erika Tissino, Dania Benedetti, et al.. (2014). The Role of CD49d in Chronic Lymphocytic Leukaemia: Microenvironmental Interactions and Clinical Relevance. 80–87. 1 indexed citations

13.

Zucchetto, Antonella, Dania Benedetti, Erika Tissino, et al.. (2013). CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. Blood. 122(19). 3317–3321. 38 indexed citations

14.

Rossi, Francesca Maria, Maria Ilaria Del Principe, Davide Rossi, et al.. (2010). Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells. Journal of Translational Medicine. 8(1). 23–23. 18 indexed citations

15.

Bomben, Riccardo, Michele Dal Bo, Daniela Capello, et al.. (2010). Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort. Leukemia & lymphoma. 51(5). 822–838. 8 indexed citations

16.

Zucchetto, Antonella, Dania Benedetti, Claudio Tripodo, et al.. (2009). CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival. Cancer Research. 69(9). 4001–4009. 118 indexed citations

17.

Trentin, Livio, Liliana Terrin, Massimo Degan, et al.. (2007). Telomerase as a new prognostic factor in B-cell chronic lymphocytic leukemia. Haematologica. 92. 192–192. 2 indexed citations

18.

Zucchetto, Antonella, Riccardo Bomben, Michele Dal Bo, et al.. (2006). ZAP‐70 expression in B‐cell chronic lymphocytic leukemia: Evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV_H mutations. Cytometry Part B Clinical Cytometry. 70B(4). 284–292. 34 indexed citations

19.

Zucchetto, Antonella, Paolo Sonego, Massimo Degan, et al.. (2006). Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance. Journal of Translational Medicine. 4(1). 11–11. 8 indexed citations

20.

Zucchetto, Antonella, Paolo Sonego, Massimo Degan, et al.. (2004). Signature of B‐CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. Journal of Cellular Physiology. 204(1). 113–123. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact